Trulieve Cannabis Corp. (TSE:TRU – Free Report) – Equities research analysts at Cormark decreased their FY2026 earnings per share (EPS) estimates for Trulieve Cannabis in a note issued to investors on Thursday, May 8th. Cormark analyst J. Pytlak now anticipates that the company will post earnings per share of $0.08 for the year, down from their previous forecast of $0.11. Cormark has a “Moderate Buy” rating on the stock.
Several other research firms have also weighed in on TRU. Craig Hallum upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a research note on Wednesday, February 26th. Roth Capital upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a report on Monday, March 3rd.
Trulieve Cannabis Stock Performance
Trulieve Cannabis Company Profile
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
See Also
- Five stocks we like better than Trulieve Cannabis
- Expert Stock Trading Psychology Tips
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- How to Plot Fibonacci Price Inflection Levels
- Why Boeing May Be Ready to Take Off After Latest Developments
- How to Buy Gold Stock and Invest in Gold
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
